rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
34
|
pubmed:dateCreated |
2010-11-30
|
pubmed:abstractText |
Symptoms secondary to hormonal changes significantly impact quality of life (QoL) in patients with cancer. This cross-sectional study examines prevalence of hypogonadism and its correlation with QoL and sexual dysfunction.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1527-7755
|
pubmed:author |
pubmed-author:FleishmanStewart BSB,
pubmed-author:GuarinoMichael JMJ,
pubmed-author:HomelPeterP,
pubmed-author:KhanHinaH,
pubmed-author:MahajanDivyaD,
pubmed-author:MirzoyevTahirT,
pubmed-author:MohammadFarhanF,
pubmed-author:RosenwaldVictoriaV,
pubmed-author:Strebel-AmrheinRotraudR,
pubmed-author:SuhailMohammad FMF,
pubmed-author:SuppiahKathiresanK,
pubmed-author:WozniakTimothy FTF
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5054-60
|
pubmed:meshHeading |
pubmed-meshheading:20975075-Aged,
pubmed-meshheading:20975075-Chromatography, Liquid,
pubmed-meshheading:20975075-Cross-Sectional Studies,
pubmed-meshheading:20975075-Humans,
pubmed-meshheading:20975075-Hypogonadism,
pubmed-meshheading:20975075-Luminescence,
pubmed-meshheading:20975075-Male,
pubmed-meshheading:20975075-Mass Spectrometry,
pubmed-meshheading:20975075-Middle Aged,
pubmed-meshheading:20975075-Neoplasms,
pubmed-meshheading:20975075-Prevalence,
pubmed-meshheading:20975075-Quality of Life,
pubmed-meshheading:20975075-Testosterone
|
pubmed:year |
2010
|
pubmed:articleTitle |
Testosterone levels and quality of life in diverse male patients with cancers unrelated to androgens.
|
pubmed:affiliation |
Continuum Cancer Centers of New York, Beth Israel Medical Center and St Luke's-Roosevelt Hospital, New York, NY, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|